The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Fact checked by Jennifer Klump People who use Wegovy for weight management may be at higher risk for hair loss, according to ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

compared to about 16% of those taking Wegovy, the AP reported, citing the study. Researchers explained in the study that ...

compared to about 16% of those taking Wegovy, the study found. Weight loss was about 6% lower in men than in women in both ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound ... loss in adults with a BMI of 30 or higher if they have a related condition like ...

The U.S. Food and Drug Administration has accepted Novo Nordisk’s application for an oral version of its blockbuster weight loss drug Wegovy. The Danish drugmaker – which has its U.S ...